| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.01B | -7.9% |
| Cost of Revenue | $1.80B | -6.5% |
| Gross Profit | $1.21B | -9.9% |
| R&D Expense | $66.1M | -7.6% |
| SG&A Expense | $615.9M | -9.9% |
| Operating Income | $527.1M | -10.3% |
| Pre-tax Income | $429.2M | -14.1% |
| Income Tax | $188.4M | +378.7% |
| Net Income | $331.8M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Inventory | $360.3M | -18.4% |
| Current Assets | $1.39B | +4.0% |
| Total Assets | $6.73B | +9.3% |
| Current Liabilities | $801.6M | +9.3% |
| Long-term Debt | $2.15B | +21.0% |
| Total Liabilities | $3.50B | +15.8% |
| Stockholders' Equity | $3.24B | +3.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $643.1M | +21.8% |
| Capital Expenditures | $74.0M | +4.2% |
| Investing Cash Flow | -$758.4M | +34.9% |
| Financing Cash Flow | $146.2M | -71.7% |
| Free Cash Flow | $569.1M | +24.5% |
| -41.5% |
| EPS (Basic) | $2.00 | -41.5% |
| EPS (Diluted) | $1.97 | -41.5% |